Skip to main content
ArticleOPEN ACCESS

Second to none

Blood
DOI: 10.1182/blood-2012-07-439158
6Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Usmani et al provide important information on second primary malignancies in patients treated with thalidomide and lenalidomide in the Arkansas total therapy trials.

Cite

CITATION STYLE

APA

Rajkumar, S. V. (2012, August 23). Second to none. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2012-07-439158

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free